Viewing StudyNCT00083941



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00083941
Status: COMPLETED
Last Update Posted: 2020-10-19
First Post: 2004-06-03

Brief Title: A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer
Sponsor: Oxford BioMedica
Organization: Oxford BioMedica

Conditions & Keywords Data

Conditions:
Name
Carcinoma Renal Cell
Keywords:
Name View
Stage IV Renal Cell Cancer View
Renal Cell Cancer View
Requiring IL-2 treatment View